AYHAM AL ASHKAR, MD
Medical Oncology Physician · ROYAL OAK, MI
Individual Active NPI 1417084799
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 676 | 225,191 | $9,772,665 | $3,163,150 | $2,515,873 |
| 2023 | 644 | 162,842 | $8,574,945 | $2,780,165 | $2,213,989 |
| 2022 | 653 | 163,294 | $9,462,092 | $3,054,484 | $2,433,721 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J1439 | Injection, ferric carboxymaltose, 1 mg | 92,250 | $1 | $1 |
| J9263 | Injection, oxaliplatin, 0.5 mg | 25,000 | $0 | $0 |
| J1453 | Injection, fosaprepitant, 1 mg | 6,900 | $0 | $0 |
| J0897 | Injection, denosumab, 1 mg | 4,260 | $26 | $21 |
| J9271 | Injection, pembrolizumab, 1 mg | 4,000 | $57 | $45 |
| J1449 | Injection, eflapegrastim-xnst, 0.1 mg | 3,564 | $25 | $20 |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | 3,290 | $8 | $6 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 2,967 | $0 | $0 |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 2,820 | $3 | $2 |
| Q5123 | Injection, rituximab-arrx, biosimilar, (riabni), 10 mg | 2,370 | $40 | $32 |
| J2469 | Injection, palonosetron hcl, 25 mcg | 2,290 | $1 | $1 |
| J0640 | Injection, leucovorin calcium, per 50 mg | 1,812 | $4 | $4 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Medical Oncology Physician | 207RX0202X | ✓ | 4301078715 | MI |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Medical Oncology Physician providers in Michigan
- NPI 1811957756
- NPI 1992773741
- NPI 1629146154
- NPI 1548475387
- NPI 1043426521
- NPI 1578990727
- NPI 1609829001
- NPI 1417174699
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.